RVMD · Revolution Medicines, Inc. · Documents
$205.26
+0.78 (+0.38%)
At close · Sep 30
Return incl. dividend (before tax)
Market Cap
$43.93B
Shares
214.34M
Volume · Sep 30
1.85M
Avg daily vol (3M)
1.94M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-09-01 | 2026-08-27 | |
| 8-K | 2026-08-26 | — | |
| 8-K | 2026-08-05 | — | |
| 10-Q | 2026-08-05 | 2026-06-30 | |
| 8-K | 2026-06-22 | 2026-06-18 | |
| Investor Event Transcript | 2026-05-31 | 2026-06-30 | |
| 10-Q | 2026-05-06 | 2026-03-31 | |
| 8-K | 2026-05-06 | — | |
| DEF 14A | 2026-04-27 | 2026-06-18 | |
| 8-K | 2026-04-17 | 2026-04-14 | |
| 8-K | 2026-04-16 | 2026-04-14 | |
| 8-K | 2026-04-13 | — | |
| 10-K | 2026-02-25 | 2025-12-31 | |
| 8-K | 2026-02-25 | — | |
| 8-K | 2025-11-05 | — | |
| 10-Q | 2025-11-05 | 2025-09-30 | |
| 8-K | 2025-10-17 | 2025-10-16 | |
| 8-K | 2025-09-10 | — | |
| 10-Q | 2025-08-06 | 2025-06-30 | |
| 8-K | 2025-08-06 | — | |
| 8-K | 2025-06-27 | 2025-06-26 | |
| 8-K | 2025-06-24 | 2025-06-23 | |
| 8-K | 2025-06-18 | — | |
| 8-K | 2025-05-07 | — | |
| 10-Q | 2025-05-07 | 2025-03-31 | |
| DEF 14A | 2025-04-29 | 2025-06-26 | |
| 10-K | 2025-02-26 | 2024-12-31 | |
| 8-K | 2025-02-26 | — | |
| 8-K | 2024-12-05 | 2024-12-03 | |
| 8-K | 2024-12-02 | — | |
| 8-K | 2024-11-06 | — | |
| 10-Q | 2024-11-06 | 2024-09-30 | |
| 8-K | 2024-10-25 | — | |
| 8-K | 2024-10-23 | — | |
| 10-Q | 2024-08-07 | 2024-06-30 | |
| 8-K | 2024-08-07 | 2024-08-05 | |
| 8-K | 2024-07-15 | — | |
| 8-K | 2024-06-24 | 2024-06-20 | |
| 8-K | 2024-05-08 | — | |
| 10-Q | 2024-05-08 | 2024-03-31 | |
| DEF 14A | 2024-04-25 | — | |
| 10-K | 2024-02-26 | 2023-12-31 | |
| 8-K | 2024-02-26 | — | |
| 8-K | 2024-01-09 | — | |
| 8-K/A | 2023-12-26 | 2023-11-08 | |
| 8-K | 2023-11-09 | 2023-11-08 | |
| 8-K | 2023-11-06 | — | |
| 10-Q | 2023-11-06 | 2023-09-30 | |
| 8-K | 2023-11-01 | — | |
| 8-K | 2023-10-23 | 2023-10-22 |
Showing 1–50 of 105 filings
Key facts
CIK
1628171
CUSIP
76155X100
13F (30d)
17 filings
14 filers
Visit website
Investor relations